In Points: Know all about Johnson & Johnson’s single-dose vaccine approved in India

The vaccine claims to provided protection against the Delta strain and other developing variants.

In-Points all-about-Johnson-Johnsons-singledose-vaccine new-vaccine-in-India

Union Health Minister Mansukh Mandaviya today announced that India has granted US pharmaceutical giant Johnson & Johnson's single-dose Covid-19 vaccine an Emergency Use Authorization (EUA).

"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against," he tweeted.

  • A supply agreement with domestic vaccine manufacturer Biological E Limited would bring the vaccine to India.
  • Johnson & Johnson stated that this is a significant step toward making their Covid-19 vaccine more widely available to help end the pandemic.
  • A statement from Johnson & Johnson's India spokesperson said, “We are pleased to announce that on August 7, 2021, the Government of India issued Emergency Use Authorisation (EUA) for the Johnson & Johnson Covid-19 single-dose vaccine in India, to prevent Covid-19 in individuals 18 years of age and older."
  • In clinical studies, the US pharmaceutical giant claims that its vaccine was 85 per cent effective against serious illness and 66% efficient in avoiding moderate to severe disease.

In addition, the vaccination provided protection against the Delta strain and other developing variants.

Also Read: Delta variant spread takes global Coronavirus tally over 200M

  • The most common side-effects of Johnson and Johnson's vaccine, according to the US FDA, are injection site pain (48.6%), headache (39%), fatigue (38.2%), and aches and pains (33.2%). Other adverse effects included a high (in few) to mild fever.
  • Both the Pfizer/BioNTech and Moderna vaccines elicit an immunological response using new messenger RNA technology, and both require two injections. A more conventional technique is used in the one-shot J&J vaccine, which uses a common cold virus to deliver coronavirus proteins into cells and stimulate an immune response.

  • At typical refrigerator temperatures, J&J's vaccine stays stable for at least three months. Meanwhile, the Moderna vaccine must be delivered frozen, and the Pfizer/BioNTech alternative must be shipped and stored at even colder sub-Arctic conditions.
  • With this, India now has five Covid vaccines that have been approved for emergency use. Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, and Moderna are the other four.


Trending